Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCI-27483 + Gemcitabine in Pancreatic Cancer
NCT01020006Phase 2Completed
- Sponsor
- Pharmacyclics
- Start
- Nov 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PCI-27483 in pancreatic ductal adenocarcinoma (PDAC), sponsored by Pharmacyclics. Started Nov 2009; status: completed.
02
Drugs
PCI-27483
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01020006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01020006.